Sausville, E.
107  Ergebnisse:
Personensuche X
?
1

Major clinical response to nivolumab in relapsed/refractory..:

Yared, J A ; Hardy, N ; Singh, Z...
Bone Marrow Transplantation.  51 (2016)  6 - p. 850-852 , 2016
 
?
2

Use of "Virtual" High-Dose-Rate (HDR) Brachytherapy via Spa..:

Snider III, J.W. ; Francis, M. ; Hanna, N....
International Journal of Radiation Oncology*Biology*Physics.  90 (2014)  1 - p. S767 , 2014
 
?
3

570 Phase 1 study of XMT-1001, a novel water soluble campto..:

Fram, R.J. ; Garbo, L.E. ; Weiss, G.J....
European Journal of Cancer Supplements.  8 (2010)  7 - p. 180 , 2010
 
?
4

1207 Results of study PX-171–007 a phase 1b/2 study of carf..:

Gordon, M. ; Infante, J. ; Papadopoulos, K.P....
European Journal of Cancer Supplements.  7 (2009)  2 - p. 122-123 , 2009
 
?
5

8 INVITED Pitfalls for cancer drug discovery with "genetic"..:

Sausville, E.
European Journal of Cancer Supplements.  6 (2008)  12 - p. 7 , 2008
 
?
6

139 POSTER Phase I dose escalation safety/tolerance study o..:

Stiede, K. ; Eder, J. ; Anthony, S....
European Journal of Cancer Supplements.  4 (2006)  12 - p. 45 , 2006
 
?
 
?
 
?
9

46 Biological testing of the tyrphostin tyrosine kinase inh..:

Egilegor, E. ; Mendoza, L. ; Gallot, N....
European Journal of Cancer Supplements.  2 (2004)  8 - p. 18 , 2004
 
?
10

Versipelostatin: Unfolding an Unsweetened Death:

Sausville, E. A.
JNCI Journal of the National Cancer Institute.  96 (2004)  17 - p. 1266-1267 , 2004
 
?
11

190 Adaphostin (NSC680410) down regulates VEGF expression i..:

Kaur, G. ; Hollingshead, M. ; Fisher-Nielsen, K....
European Journal of Cancer Supplements.  2 (2004)  8 - p. 59 , 2004
 
?
12

The hollow fibre model in cancer drug screening:

Decker, S. ; Hollingshead, M. ; Bonomi, C.A...
European Journal of Cancer.  40 (2004)  6 - p. 821-826 , 2004
 
?
13

Scientific summation and future goals:

Sausville, E.A.
Journal of Controlled Release.  74 (2001)  1-3 - p. 1-6 , 2001
 
?
 
1-15